** Brokerage Piper Sandler raises targets on many medtech
companies, including Boston Scientific BSX.N Teleflex TFX.N
and Stryker SYK.N
** Says, it recommends Alphatec Holdings ATEC.O and DexCom
DXCM.O , with DexCom as its favorite pick of the year
** "We anticipate some concern around the political backdrop
here in the U.S. but doubt medtech will be pressured regardless
of who wins the Presidency" - Piper Sandler
** The brokerage sees little risk related to GLP-1 drugs for
medtech
** Adds that Boston Scientific's acquisition of Axonics
AXNX.O is a positive catalyst for the sector
** ATEC rose 22.4% and DXCM was up 9.6% in 2023
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))